[1]
2019. The Impact of CYP2C9 and VKORC1 Polymorphism in Patient’s Response to Warfarin and Acenocoumarol. Journal of Medical Biomedical and Applied Sciences. 7, 7 (Tem. 2019), 260–266. DOI:https://doi.org/10.15520/jmbas.v7i7.193.